ASND · Ascendis Pharma A/S · Documents

$238.90 +4.57 (+1.95%)

Market Cap

$15.69B

65.80M

Volume · Oct 21 662.12K Avg daily vol (3M) 688.48K

The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.

Type	AI summary	Filing Date	Period
6-K	—	2023-06-14	—
6-K	—	2023-06-06	2023-06-05
6-K	—	2023-06-01	—
6-K	—	2023-05-31	—
6-K	—	2023-05-31	—
6-K	—	2023-05-11	—
6-K	—	2023-05-02	—
6-K	—	2023-05-01	—
6-K	—	2023-04-27	2023-03-31
6-K	—	2023-04-27	—
6-K	—	2023-04-12	—
6-K	—	2023-04-03	—
6-K	—	2023-03-30	—
6-K	—	2023-03-15	—
6-K	—	2023-03-13	—
6-K	—	2023-03-01	—
6-K	—	2023-02-16	—
20-F	—	2023-02-16	2022-12-31
6-K	—	2023-02-15	—
6-K	—	2023-01-11	—
6-K	—	2023-01-09	—
6-K	—	2023-01-09	—
6-K	—	2023-01-03	—
6-K	—	2022-12-14	—
6-K	—	2022-12-05	—
6-K	—	2022-11-14	—
6-K	—	2022-11-14	—
6-K	—	2022-11-14	—
6-K	—	2022-11-09	—
6-K	—	2022-11-02	2022-09-30
6-K	—	2022-11-02	—
6-K	—	2022-10-31	—
6-K	—	2022-10-12	—
6-K	—	2022-10-03	—
6-K	—	2022-09-30	—
6-K	—	2022-09-14	—
6-K	—	2022-09-12	—
6-K	—	2022-08-31	—
6-K	—	2022-08-12	—
6-K	—	2022-08-10	—
6-K	—	2022-08-10	—
6-K	—	2022-08-10	2022-06-30
6-K	—	2022-07-13	—
6-K	—	2022-06-30	—
6-K	—	2022-06-15	—
6-K	—	2022-06-02	—
6-K	—	2022-05-23	—
6-K	—	2022-05-11	2022-03-31
6-K	—	2022-05-11	—
6-K	—	2022-05-11	—

Showing 151–200 of 299 filings

Key facts CIK 1612042 CUSIP K08588103 13F (30d) 32 filings 32 filers Visit website Investor relations